{"url":"https://www.moneycontrol.com/news/companies-2/alembic-pharma-gets-usfda-nod-for-generic-drug-3-12807212.html","title":"Alembic Pharma gets USFDA nod for generic drug","description":"The company has received final approval from the US Food \u0026 Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Betamethasone Valerate FoamAlembic Pharmaceuticals","content":"Alembic Pharmaceuticals on August 26 said it has received approval from the US health regulator to market a generic medication used to treat moderate-to-severe psoriasis of the scalp. The company has received final approval from the US Food \u0026 Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Betamethasone Valerate Foam, the drug firm said in a statement. The approved ANDA is therapeutically equivalent to the reference listed drug product Luxiq Foam (0.12 per cent), of Norvium Bioscience, LLC (Norvium). Shares of Alembic Pharmaceuticals ended 0.97 percent down at Rs 1,089.90 apiece on the BSE. ","cleaned_content":"alembic pharmaceuticals on august \u003cTWO_TEN\u003e said it has received approval from the us health regulator to market a generic medication used to treat moderate to severe psoriasis of the scalp the company has received final approval from the us food drug administration usfda for its abbreviated new drug application anda for betamethasone valerate foam the drug firm said in a statement the approved anda is therapeutically equivalent to the reference listed drug product luxiq foam \u003cZERO_PERCENT\u003e of norvium bioscience llc norvium shares of alembic pharmaceuticals ended \u003cZERO_PERCENT\u003e down at rs \u003cONE_THOUSAND\u003e apiece on the bse","timestamp":"2024-08-26T17:26:00+05:30","market_timestamp":"2024-08-27T09:15:00+05:30","off_market_hours":true}